D. Ignar-Trowbridge

Mutations of the Ki-ras oncogene in endometrial carcinoma.

A. Berchuck, J. Boyd, J. McLachlan, 1992, American journal of obstetrics and gynecology.

Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.

K. Korach, J. McLachlan, M. Parker, 1993, Molecular endocrinology.

p53 gene mutations in human endometrial carcinoma

J. Boyd, M. Tsao, J. McLachlan, 1992, Molecular carcinogenesis.

Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.

K. Korach, J. McLachlan, M. Parker, 1996, Endocrinology.

Diethylstilbestrol stimulates persistent phosphatidylinositol lipid turnover by an estrogen receptor-mediated mechanism in immature mouse uterus.

K. Korach, J. Putney, J. McLachlan, 1991, Endocrinology.

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

K. Korach, K. Nelson, J. McLachlan, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Cross talk between peptide growth factor and estrogen receptor signaling systems.

K. Korach, J. McLachlan, C. Teng, 1995, Environmental health perspectives.